Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 2 Issue 11, November 2017

Sleep no more

Recombinant proteins based on APOL1 and APOL3 can kill pathogenic Trypanosoma brucei subspecies, including a variant that is effective against T.b. gambiense infection in mice, suggesting a potential therapeutic for sleeping sickness.

See Fontaine, F., Lecordier, L. et al. 2, 1500–1506 (2017)

Image: D. Perez-Morga and the Université Libre de Bruxelles, Cover Design: Karen Moore

Editorial

  • An increased focus on identifying disease hotspots and pre-emptive intervention will be key to halting outbreaks before they become established, but political and economic obstacles cannot be ignored if ambitious new targets to reduce global cholera mortality tenfold are to be achieved.

    Editorial

    Advertisement

Top of page ⤴

News & Views

  • The Uncultivated Bacteria and Archaea dataset is a foundational collection of 7,903 genomes from uncultivated microorganisms. It highlights how microbial diversity is readily recovered using current tools and existing metagenomic datasets to help piece together the tree of life.

    • Lindsey M. Solden
    • Kelly C. Wrighton
    News & Views
  • Two studies identify circulating monocytes as the primary cellular target of Zika virus infection in human blood. Monocytes are an ideal target as they have the potential to be used as a Trojan horse to infiltrate immune-sheltered tissues, including placenta, testes and the brain, to spread Zika virus.

    • Kellie Ann Jurado
    • Akiko Iwasaki
    News & Views
Top of page ⤴

Research

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links